| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | — | +893.0% |
| R&D Expense | $5.2M | — | -21.4% |
| SG&A Expense | $4.9M | — | -13.0% |
| Operating Income | -$8.3M | — | +30.6% |
| Interest Expense | $88K | — | -90.7% |
| Net Income | -$7.0M | — | +3.2% |
| EPS (Basic) | -$0.04 | — | +81.8% |
| EPS (Diluted) | -$0.04 | — | +81.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.6M | -48.2% | -4.6% |
| Accounts Receivable | $2.0M | +0.0% | +240.3% |
| Current Assets | $47.1M | -11.7% | +164.8% |
| Total Assets | $51.9M | -11.5% | +115.0% |
| Current Liabilities | $13.9M | +9.4% | -31.2% |
| Total Liabilities | $16.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.5M | — | +20.3% |
| Capital Expenditures | $15K | — | -70.6% |
| Investing Cash Flow | -$2.5M | — | -113.4% |
| Financing Cash Flow | -$27K | — | +99.3% |
| Free Cash Flow | -$6.5M | — | +20.6% |
| -44.6% |
| Stockholders' Equity | $28.4M | -14.0% | +1029.5% |